Prof. Dr. Tanja Schneider
Institute for Pharmaceutical Microbiology
tschneider@uni-bonn.de View member: Prof. Dr. Tanja Schneider
RSC advances
Full details on the design, strategies and tactics for development of a novel synthetic sequence to farnesyl lipid I and II analogs is reported. The modular route was based on a three coupling strategy involving an efficient solid phase synthesis of the elaborate peptide fragment, which proceeded with excellent yield and stereoselectivity and was efficiently applied for the convergent synthesis of 3-lipid I and II. Furthermore, the generality of this route was demonstrated by synthesis of 3-lipid I congeners that are characteristic for and . All 3-lipid I and II building blocks were obtained in high purity revealing high spectroscopic resolution.
This journal is © The Royal Society of Chemistry.
PMID: 35702425
Institute for Pharmaceutical Microbiology
tschneider@uni-bonn.de View member: Prof. Dr. Tanja Schneider